Dr. Reddy's Laboratories Limited Stock NSE India S.E.
Stocks
INE089A01031
Pharmaceuticals
| Market Cap | 1,024B 10.64B 9.3B 8.58B 7.89B 14.95B 15.21B 102B 40.21B 501B 39.97B 39.09B 1,725B | P/E 2027 * |
24.4x | P/E 2028 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 991B 10.3B 9.01B 8.31B 7.64B 14.47B 14.72B 99.21B 38.93B 485B 38.69B 37.85B 1,670B | EV / Sales 2027 * |
2.79x | EV / Sales 2028 * | 2.46x |
| Free-Float |
70.07% | Yield 2027 * |
0.63% | Yield 2028 * | 0.68% |
Last Transcript: Dr. Reddy's Laboratories Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 2019-06-30 |
| Director of Finance/CFO | - | 2024-07-31 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 2014-05-12 | |
Gunupati Prasad
CHM | Chairman | 65 | 2013-04-01 |
Leo Puri
BRD | Director/Board Member | 65 | 2018-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 10.8B | |
| -0.39% | -5.47% | +48.92% | +157.03% | 1,028B | |
| -2.35% | -5.31% | +60.73% | +56.79% | 611B | |
| +1.54% | -2.30% | +32.47% | +83.13% | 432B | |
| +0.98% | -1.40% | +29.49% | +23.12% | 323B | |
| -0.34% | -3.10% | +27.00% | +43.66% | 277B | |
| +1.63% | -11.76% | +19.72% | +23.20% | 257B | |
| +3.39% | +2.29% | -23.68% | -38.33% | 217B | |
| +0.88% | -2.70% | +22.40% | +57.15% | 192B | |
| +1.53% | -2.73% | +21.14% | +70.51% | 161B | |
| Average | +0.72% | -5.24% | +26.47% | +52.92% | 388.7B | |
| Weighted average by Cap. | +0.21% | -5.52% | +36.04% | +77.64% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 356B 3.7B 3.23B 2.98B 2.74B 5.2B 5.28B 35.61B 13.97B 174B 13.89B 13.59B 600B | 395B 4.1B 3.59B 3.31B 3.04B 5.76B 5.86B 39.49B 15.49B 193B 15.4B 15.06B 665B |
| Net income | 42.23B 439M 384M 354M 325M 617M 627M 4.23B 1.66B 20.64B 1.65B 1.61B 71.14B | 53.11B 552M 483M 445M 409M 775M 789M 5.32B 2.09B 25.96B 2.07B 2.03B 89.48B |
| Net Debt | -32.67B -340M -297M -274M -252M -477M -485M -3.27B -1.28B -15.97B -1.27B -1.25B -55.03B | -54.24B -564M -493M -455M -418M -792M -805M -5.43B -2.13B -26.51B -2.12B -2.07B -91.38B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
